NUS
What one share of Nu Skin Enterprises holds
Wholesale – Drugs, Proprietaries and Druggists' Sundries
Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, our revenue of
Nu Skin Enterprises’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $27.71 |
|---|---|
| Profit | −$4.36 |
| Capex (buildings and equipment) | $0.81 |
| Free cash flow | $0.22 |
| Dividends | $0.23 |
| Cash and investments | $3.90 |
| Debt | $4.39 |
| Book value | $11.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $39.36 | $2.55 | $0.90 | $4.01 | — | $11.98 |
| 2017 | $41.55 | $2.36 | $1.10 | $4.42 | — | $13.34 |
| 2018 | $47.44 | $2.16 | $1.25 | $2.34 | — | $14.17 |
| 2019 | $43.28 | $3.10 | $1.18 | $2.00 | — | $15.76 |
| 2020 | $48.93 | $3.63 | $1.21 | $5.98 | — | $17.59 |
| 2021 | $52.42 | $2.86 | $1.33 | $1.42 | — | $18.32 |
| 2022 | $44.05 | $2.07 | $1.17 | $0.97 | — | $18.14 |
| 2023 | $39.49 | $0.17 | $1.17 | $1.21 | — | $16.63 |
| 2024 | $34.88 | −$2.95 | $0.84 | $1.41 | — | $13.10 |
| 2025 | $29.53 | $3.18 | $0.68 | $0.91 | — | $16.73 |